Magenta therapeutics appoints caren deardorf as chief commercial officer

Cambridge, mass.--(business wire)--magenta therapeutics, inc. (nasdaq: mgta), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced the appointment of caren deardorf as the company's first chief commercial officer. “caren has a highly sought-after balance of commercial success and hands-on experience, and we welcome her wide-ranging enterprise leadership expertise,” said jason gardner, d.phil., ch
DNTH Ratings Summary
DNTH Quant Ranking